RYOJ RYOJBABA CO LTD
FollowCOM (common), issuer CIK 2012600
3 managers (3 13F filers) reported a position in RYOJ shares at 2026-06-30, 97 shares in all. 0 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 3
- 13F filers
- 3
- New
- 0
- Added
- 2
- Reduced
- 1
- Sold out
- 0
- Shares held by filers
- 97
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Baba Ryoji(group Miracle Exploration Technologies Ltd.)
8,664,000 shares, 75.01% in a 13D/A as of 2026-11-17,0001493152-26-053082
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Baba Ryojidirector, officer (CEO), 10% owner | 2026-11-17 | +640,000 J | $0 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| JPMORGAN CHASE & COin group JPMORGAN CHASE & CO | 63 | $160 | <0.01% | +2 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 25 | $64 | <0.01% | -4,313 | 13F-HRTimelineGroup |
| Caitong International Asset Management … | 9 | $23 | <0.01% | +8 | 13F-HRTimeline |
Events
Baba Ryoji and 1 other reporting person acquired 640,000 RYOJ shares on 2026-11-17, Form 4 filed 2026-11-18. 0001493152-26-053087
Accepted , ingestedBaba Ryoji and 1 other reporting person reported 8,664,000 RYOJ shares, 75.01% of the class, as of 2026-11-17, in a 13D/A filed 2026-11-18. 0001493152-26-053082
Accepted , ingested